Interpatient genetic variability of HIV-1 group O

AIDS

Volumn 13, Issue 1, 1999, Pages 41-48

  Janssens, Wouter ^c   Heyndrickx, Leo ^d   Van Auwera, Gert der ^d   Nkengasong, John ^d   Beirnaert, Els ^a   Vereecken, Katleen ^d   Coppens, Sandra ^a   Willems, Betty ^d   Fransen, Katrien ^d   Peeters, Martine ^b   Ndumbe, Peter ^d   Delaporte, Eric ^b   Van Groen, Guido der ^d  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d NONE

Author keywords

env gp160; gag p24; HIV 1 group O; Subtype; Variability

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 160;

ARTICLE; CAMEROON; ENVELOPE GENE; EVOLUTION; GABON; GENE CLUSTER; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS ISOLATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, VIRAL; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PHYLOGENY; SEQUENCE ANALYSIS; VARIATION (GENETICS);

EID: 2442726472     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00006     Document Type: Article

References (48)

1. 1. Charneau P, Borman AM, Quillant C, et al.: Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994, 205:247-253.
2. ANT70 virus in Cameroon and Gabon [letter]. AIDS 1993, 7:1536-1538.
3. 3. Zekeng L, Gürtler L, Afane Ze E, et al.: Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results [letter]. AIDS 1994, 8:1626-1628.
4. 4. Peeters M, Gueye A, Mboup S, et al.: Geographical distribution of HIV-1 group O viruses in Africa. AIDS 1997, 11:493-498.
5. 5. Bunt JC, Golden AM, Vallari A, et al.: Molecular and serologic characterization of four HIV-1 group O sera from Equatorial Guinea. AIDS Res Hum Retroviruses 1995, 11 (suppl 1):S144.
6. 6. Heyndrickx L, Alary M, Janssens W, Davo N, van der Groen G: HIV-1 group O and group M dual infection in Bénin. Lancet 1996, 347:902-903.
7. 7. Kabeya CM, Esu-Williams E, Eni E, Peeters M, Saman E, Delaporte E: Evidence for HIV-1 group O infection in Nigeria [letter]. Lancet 1995, 346:308.
8. 8. Songok EM, Libondo DK, Rotich MC, Oogo SA, Tukei PM: Surveillance for HIV-1 subtypes O and M in Kenya [letter]. Lancet 1996, 347:1700.
9. 9. vanden Haesevelde M, Decourt J-L, De Leys RJ, et al.: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994, 68:1586-1596.
10. 10. Loussert-Ajaka L, Chaix M-L, Korber B, et al.: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995, 69:5640-5649.
11. 11. Hampl H, Sawitzky D, Stoffler-Meilicke M, et al.: First case of HIV-1 subtype O infection in Germany. Infection 1995, 23:369-370.
12. 12. Mas A, Quiñones-Mateu ME, Soriano V, Domingo E: Env gene characterization of the first HIV type 1 group O Spanish isolate. AIDS Res Hum Retroviruses 1996, 12:1647-1649.
13. 13. Jonassen TO, Strene-Johansen K, Berg ES, et al.: Sequence analysis of HIVA group O from Norwegian patients infected in the 1960s. Virology 1997, 231:43-47.
14. 14. Rowe PM: HIV-1 group O infection identified in USA [news]. Lancet 1996, 348:116.
15. 15. Takehisa J, Zekeng L, Miura T, et al: Triple HIV-1 infection with group O and group M of different clades in a single Cameroonian AIDS patient. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:81-82.
16. 16. Loussert-Ajaka I, Ly TD, Chaix ML, et al.: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994, 343:1393-1394.
17. 17. Schable C, Zekeng L, Pau CP, et al.: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994, 344:1333-1334.
18. IIIB in sera of African and Belgian HIV-1-infected individuals. AIDS 1994, 8:1089-1096.
19. 19. Nyambi P, Nkengasong J, Peeters M, et al. : Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis 1995, 172:1228-1237.
20. 20. Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, Brun-Vézinet F: HIV-1 group O sensitivity to antiretroviral drugs [letter]. AIDS 1995, 9:977-978.
21. 21. Descamps D, Collin G, Letourneur F, et al.: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 1997, 71:8893-8898.
22. 22. Braaten D, Franke EK, Luban J: Cyclophilin A is required for the replication of group M human immunodeficiency virus SIVcpz-gab but not group O HIV-1 or other primate immunodeficiency viruses. J Virol 1996, 70:4220-4227.
23. ANT70 virus in Cameroon and Gabon [letter]. AIDS 1993, 7:1536-1538.
24. 24. Janssens W, Nkengasong JN, Heyndrickx L, et al.: Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon [lettter]. AIDS 1994, 8:1012-1013.
25. 25. Delaporte E, Janssens W, Peeters M, et al.: Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS 1996, 10:903-910.
26. 26. Zhang L, Huang Y, He T, Cao Y, Ho DD: HIV-1 subtype and second-receptor use [letter]. Nature 1996, 383:768.
27. 27. Cecilia D, Kewalramani VN, O'Leary J, et al.: Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998, 72:6988-6996.
28. 28. Louwagie J, McCutchan FE, Peeters M, et al.: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993, 7:769-780.
29. 29. Korber B, Hahn B, Foley B, et al.: Human Retroviruses and AIDS 1997. Los Alamos: Los Alamos National Laboratory; 1997.
30. 30. Gao F, Robertson DL, Carruthers CD, et al.: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998, 72:5680-5698.
31. 31. Carr JK, Salminen MO, Albert J, et al.: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998, 247:22-31.
32. 32. Myers G, Korber B, Foley B, Jeang K-T, Mellors JW, Wain-Hobson S: Human Retroviruses and AIDS 1996. Los Alamos: Los Alamos National Laboratory; 1996.
33. 33. Hunt JC, Golden AM, Lund JK, et al.: Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from Equatorial Guinea. AIDS Res Hum Retroviruses 1997, 13:995-1005.
34. 34. Hackett J Jr, Zekeng L, Brennan CA, et al.: Genetic analysis of HIV type 1 group O p24 gag sequences from Cameroon and Equatorial Guinea. AIDS Res Hum Retroviruses 1997, 13:1155-1150.
35. 35. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
36. 36. De Rijk P, De Wachter R: DCSE, an interactive tool for sequence alignment and secondary structure research. Comput Appl Biosci 1993, 9:735-740.
37. 37. Van de Peer Y, De Wachter R: TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 1994, 10:569-570.
38. 38. De Jong J, Simon F, van der Groen G, et al.: V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT2 cells. AIDS Res Hum Retroviruses 1996, 12:1503-1507.
39. 39. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN: Human Retroviruses and AIDS 1994. Los Alamos: Los Alamos National Laboratory; 1994.
40. 40. Kostrikis LG, Bagdades E, Cao V, Zhang L, Dimitriou D, Ho DD: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol 1995, 10:6122-6130.
41. 41. Korber BTM, Allen EE, Farmer AD, Myers GL: Heterogeneity of HIV-1 and HIV-2. AIDS 1995, 9 (suppl A):S5-S18.
42. 42. Lee W-B, Syu W-J, Du B, et al.: Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992, 89:2213-2217.
43. 43. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ: Assignment of intra chain disulphide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990, 265:10373-10382.
44. 44. Gnann JW, Nelson JA, Oldstone MBA: Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol 1987, 61:2639-2641.
45. 45. Nyambi PN, Willems B, Janssens W, et al.: The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them. AIDS Res Hum Retroviruses 1997, 13:7-17.
46. 46. Nyambi P, Nkengasong J, Lewi P, et al.: Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol 1996, 70:6235-6243.
47. 47. De Jong JJ, De Ronde A, Keulen W, Tersmette M, Goudsmit J: Minimal requirement for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 1992, 66:6777-6780.
48. 48. Zhong P, Peeters M, Janssens W, et al.: Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995, 11:239-248.